VA
BHST

Vident Advisory’s BioHarvest Sciences BHST Stock Holding History

Vident Advisory’s Portfolio BHST Stock Details BHST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,576
Closed -$50.2K – 2056
2026
Q1 		$50.2K Buy
+11,576
New +$54.5K ﹤0.01% 1821

Other funds holding BHST

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
EWM
Evercore Wealth Management New York $7.07B AUM 24.72% 1-Year Est. Return
TNA
True North Advisors Dallas, Texas $1.05B AUM 22.99% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vident Advisory's BHST Position: Q2 2026 in Review

Vident Advisory sold out of BioHarvest Sciences (BHST) in Q2 2026, closing a stake of 11,576 shares — an estimated $50.2K sold.

Vident Advisory first reported a position in BHST in Q1 2026 and held it in 1 quarter. The position peaked at $50.2K in Q1 2026. 19 funds tracked by Wall St. Rank hold BHST as of Q2 2026.

  • Vident Advisory reported no remaining BioHarvest Sciences position as of Q2 2026 after selling out during the quarter.
  • Vident Advisory sold 11,576 BioHarvest Sciences shares in Q2 2026, an estimated $50.2K.
  • Vident Advisory first reported a position in BioHarvest Sciences in Q1 2026 and held it in 1 quarter.
  • Vident Advisory's BioHarvest Sciences position peaked at $50.2K in Q1 2026.
  • 19 funds tracked by Wall St. Rank held BioHarvest Sciences as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.